Clinical Trials Browser

Terminated × Laryngeal Diseases × 30 days × Clear all

NCT01647477 2026-03-13

DEREDIA

Phase NA Terminated

Laryngeal Diseases

NCT05386550 2026-02-19

Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)

Phase 3 Terminated

166 enrolled 15 charts

Head and Neck Neoplasms, Laryngeal Diseases